The Swiss pharma giant made one of the most significant financial promises to bolster its domestic manufacturing capabilities as the Trump administration weighs levying tariffs on drugmakers.

Roche confirmed its full-year outlook with sales expected to increase in the mid-single-digit percent range at constant exchange rates. The firm added that EPS for full-year 2025 is expected to ...

Roche is committing $50 billion over the next five years for new research and development sites across the country, and the pharmaceutical company has their eyes on Indiana. Roche, a Swiss company, ...

Roche is committing $50 billion over the next five years for new research and development sites across the country, and the ...

The big pharma joined several of its peers in committing to invest billions of dollars in new and expanded manufacturing ...

President Trump wants to bring manufacturing back to the U.S. These companies say they're investing in domestic factories.

Swiss pharmaceuticals powerhouse Roche announced Tuesday it plans to invest $50 billion in the United States over the ...

Roche said it will expand existing sites and construct new U.S. manufacturing and R&D infrastructure in areas such as gene ...

Around 1,000 of these jobs will be within the company with the others in supporting roles, including construction. The ...

Roche said Tuesday it plans to invest $50 billion in the U.S. over the next five years, creating more than 12,000 new jobs in ...

Roche projected that its $50 billion manufacturing investment, to include R&D operations, will generate 1,000 jobs at the ...